Product
Humanized Anti-HER2 Monoclonal Antibody
1 clinical trial
1 indication
Indication
Breast CancerClinical trial
Experimental Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of B002 in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.Status: Completed, Estimated PCD: 2022-04-26